Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INDAPAMIDE vs INFLIXIMAB-ABDA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

INDAPAMIDE vs INFLIXIMAB-ABDA: Safety Overview

Metric INDAPAMIDE INFLIXIMAB-ABDA
Total FAERS Reports 4,876 1,810
Deaths Reported 256 18
Death Rate 5.3% 1.0%
Hospitalizations 2,945 452
Average Patient Age 68.9 yrs 46.3 yrs
% Female Patients 58.1% 61.0%
FDA Approval Date Apr 29, 1993 N/A
Manufacturer Direct_Rx N/A
Route ORAL N/A
Marketing Status Discontinued Prescription